Antipsychotic Drugs in Dementia

Abstract
The introduction of the first antipsychotic drug, chlorpromazine, into clinical practice more than 50 years ago revolutionalized psychiatry and neurology.1 The efficacy of this drug and other drugs in the phenothiazine class demonstrated that a disease considered a “mental illness” could respond to a biologically mediated therapy and heralded the introduction of other neuromodulating therapies such as levodopa for Parkinson disease.

This publication has 0 references indexed in Scilit: